Abstract Body

1. Background and purpose

The study concept will be one of the indicators of the Regions4PerMed Project - "Interregional coordination for a fast and deep uptake of personalised health" (Horizon 2020).
Personalised medicine (PM) is a treatment tailored to the patient’s characteristics, needs, and preferences. PM categorises patients according to the risk of developing a specific disease or the level of response to a specific treatment using appropriate diagnostic markers.
Objectives:
- Identification of primary barriers and facilitators during PM implementation;
- Indication of actions aimed at removing barriers during the implementation of personalised medicine at micro-, meso- and macro- regional levels;
- Indication of best practices used in European countries supporting PM implementation to healthcare systems at micro-, meso- and macro- regional levels.

2. Methods

- analysis of regional documents (regional strategies);
- a qualitative study, including:
* online surveys;
* individual in-depth interviews (partially structured);
* focus group interviews.

3. Results

- Recommendations specifying the barriers and facilitators of introducing innovative e-health interventions to healthcare systems at the micro-, meso- and macro-regional levels;
- Catalogue of best practices used in European countries supporting PM implementation at the micro-, meso- and macro-regional levels.

4. Conclusions

The results of the qualitative study will provide data for discussion on PM limitations and benefits.

EU grant
The Regions4PerMed Project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 82 5812.